This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Trials in Progress
    • Trials in Progress
      • Bladder Cancer
        • IMMORTAL
      • Kidney Cancer
        • RadiCal
    • Middle Side
      • Prostate Cancer
        • ARAMON
        • ARASEC
        • ARASTEP
        • ECLIPSE
        • FORT
        • NRG-GU 0101
        • Masofaniten (Oral EPI-7386)
        • RTIRE
        • SHORTER
        • SPLASH
    • Right Side
      • PCCTC
        • DORA
        • IRONMAN
        • PROMISE
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Ruchika Talwar, MD
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Pelvic Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Suprapubic Catheter
        Diane K. Newman, DNP FAAN BCB-PMD
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Medical Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
      • Disparities: Social Determinants of Health
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • ASTRO 2023
      • SNMMI 2023
      • ProsTIC/PCF Global Webinar 2023
      • ASCO 2023
      • AUA 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology
  4. Bladder Cancer

Conferences

Recent Abstracts
Embargoed presscast on January 28 to feature key research advances in genitourinary cancers, embargoed press release now available January 23, 2014
SUO 2013 - Session Highlights (Best Abstract Presentation): Experience with active surveillance (AS) in patients with renal mass > 4cm: Assessment of growth kinetics and outcomes December 10, 2013
SUO 2013 - Session Highlights: Evaluation of surveillance guidelines for renal cell carcinoma following partial nephrectomy December 10, 2013
SUO 2013 - Session Highlights: Targeted magnetic resonance imaging/ultrasound fusion biopsy significantly outperforms random 12-core biopsy for prediction of total prostate cancer tumor volume December 10, 2013
SUO 2013 - Session Highlights: NEUACT, a phase 2 randomized, open-label trial of DN24-02 in patients with surgically resected HER2+ urothelial cancer (UC): Updated analysis of product parameters, HER2 expression and safety December 9, 2013
SUO 2013 - Session Highlights: The influence of race on RCC incidence and survival December 9, 2013
SUO 2013 - Session Highlights: Comparative effectiveness research studies of robotic vs. open prostatectomy December 9, 2013
SUO 2013 - Session Highlights: Multicenter retrospective experience in the surgical management of isolated nodal recurrences post-nephrectomy in patients with renal cell carcinoma December 9, 2013
SUO 2013 - Session Highlights: Prostate cancer microparticles as a next generation screening tool for prostate cancer December 6, 2013
SUO 2013 - Session Highlights: Credentialing for robotic surgery December 6, 2013
SUO 2013 - Session Highlights: Marketing robotic surgery December 6, 2013
SUO 2013 - Session Highlights: Neoadjuvant androgen-targeted therapy for high-risk prostate cancer December 6, 2013
SUO 2013 - Session Highlights: Aberrations in the androgen receptor December 6, 2013
SUO 2013 - Session Highlights: Practical issues in management of bladder cancer - Case presentation December 6, 2013
SUO 2013 - Session Highlights: Translocator protein (TSPO): Potential as a novel biomarker in renal cell carcinoma December 6, 2013
SUO 2013 - Session Highlights: Micro-RNA and gene expression subtypes of high-grade, muscle invasive urothelial carcinoma December 6, 2013
SUO 2013 - Session Highlights: Combination of genomic markers and clinical variables provides superior prognostic performance in high-risk bladder cancer following radical cystectomy December 6, 2013
SUO 2013 - Session Highlights: How does FDA approval of a device differ from the approval of a drug? December 6, 2013
SUO 2013 - Session Highlights: Mechanism of castration resistance December 6, 2013
SUO 2013 - Session Highlights: Human papillomavirus in penile cancer: Rationale and feasibility for prevention December 6, 2013
Page 483 of 524
  • Start
  • Prev
  • 478
  • 479
  • 480
  • 481
  • 482
  • 483
  • 484
  • 485
  • 486
  • 487
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free